+
Site Tour

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

Dr Ingo Eitel explains why left atrial appendage occlusion can be an option in end stage kidney disease (ESKD) patients 

Related Videos

LAAO Summit - Debate: Factor XI inhibitors

LAAO Summit - Ideal vs suboptimal LAAO implant

LAAO Summit - Imaging debate: TEE

ESOC 2023: AF patient LAA case

LAAO Summit - Pre-procedural imaging

LAAO Summit - Mastering leaks

LAAO Summit 2022: AF management

LAAO Summit - Imaging debate: ICE

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

Monitoring for AF prior to PFO closure

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - Sealing the appendage

LAAO Summit - The right antithrombotic regimen

LAAO Summit - Mastering leaks

LAAO Summit 2023: Stroke severity

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline